ANRS, Emerging Infectious Diseases
ANRS, Emerging Infectious Diseases
Explore linked clinical trials.47 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| "HBV unIversal vs Point-Of-Care-based Antiviral treatMent to Prevent Mother-to-child Transmission" | Blood-Borne Infections, DNA Virus Infections, Digestive System Diseases, Hepadnaviridae infectious disease, Infections, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Not applicable | 2026-10-08 | NCT07054359 | |
| Frailty, Geriatric Syndromes and Care Pathways of Older Adults Living With HIV in West Africa | Frailty, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Recruiting | Not stated | 2026-10-02 | NCT07355413 | |
| Immunotherapy With Glatiramer Acetate in PLWHIV in Poor Immunological Responders on Antiretroviral Therapy | AIDS, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Phase 2 | 2026-10-01 | NCT07851337 | |
| Real-world Effectiveness, Safety & Immunogenicity of Chikungunya Vaccination: Ambispective Study in Reunion & French Guiana | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Recruiting | Phase 4 | 2026-09-28 | NCT06928753 | |
| Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France. | AIDS, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Phase 3 | 2026-09-02 | NCT05813964 | |
| Detection of Specific Metabolic Signatures by Nuclear Magnetic Resonance or Metabolomic NMR in Correlation With Markers of Inflammation or Immune Activation and the Risk of Developing Neurocognitive Disorders - Longitudinal Retrospective Study Nested in the ANRS12225 PEDIACAM III Cohort | Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Not stated | 2026-08-18 | NCT07770568 | |
| DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection | HIV-1-infection | Recruiting | Phase 3 | 2026-07-27 | NCT06203132 | |
| Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokombéré, Cameroon in Pregnant Women | Hepatitis B Virus - Chronic Active | Recruiting | Phase 4 | 2026-06-29 | NCT05403047 | |
| Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-positive bacterial infections, meningeal tuberculosis, meningitis, mycobacterial infectious disease, nervous system disorder, tuberculosis | Recruiting | Phase 3 | 2026-06-24 | NCT04145258 | |
| Intestinal Tissue-Resident Memory T Cells and HIV-1 Persistence During Antiretroviral Therapy | Antiretroviral Therapy; HIV Reservoir; HIV-1 Infection | Not yet recruiting | Not applicable | 2026-06-18 | NCT07656077 | |
| Prospective Cohort of People Starting Treatment for Tuberculosis Disease in France (FrenchTB) | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bacterial infectious disease, gram-positive bacterial infections, infectious disease, mycobacterial infectious disease, tuberculosis | Recruiting | Not stated | 2026-06-12 | NCT06893757 | |
| An Experimental Medicine Multicenter Trial to Evaluate the Safety and Immunogenicity of Experimental Versus Authorized SARS-CoV-2 Vaccine Candidates as a Booster Dose in Healthy Participants Previously Vaccinated With Authorized mRNA SARS-CoV-2 Vaccines. | Healthy Adults | Recruiting | Early phase 1 | 2026-06-02 | NCT07605520 | |
| Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus Disease | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Active, not recruiting | Phase 3 | 2026-05-26 | NCT05597735 | |
| Assessment of Immune Memory - Humoral and Cellular - in mPOX-infected Patients : an Ancillary Study of the ANRS0258s MOSAIC Cohort | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Not yet recruiting | Not applicable | 2026-05-18 | NCT07592429 | |
| Dose Escalation Trial of CD40.Pan.CoV Vaccine, Adjuvanted or Not, as a Booster in Adult Healthy Volunteers | Healthy Volunteers | Active, not recruiting | Phase 1 / Phase 2 | 2026-05-05 | NCT07113106 | |
| the ANRS CO21 " Extreme " Cohort (CODEX) | Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Not applicable | 2026-04-07 | NCT01520844 | |
| CABOTEGRAVIR/LENACAPAVIR DUAL LONG ACTING THERAPY (COHORT IMEA 074) | CABOTEGRAVIR; LENACAPAVIR | Not yet recruiting | Not stated | 2026-03-27 | NCT07402044 | |
| OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, immune system disorder, immunodeficiency disease, inborn error of immunity, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 2 | 2026-02-23 | NCT05587894 | |
| OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, immune system disorder, immunodeficiency disease, inborn error of immunity, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 2 | 2026-02-18 | NCT07406217 | |
| "Pregnancy and Viral Infections: Impact on Pregnant Women and Their Children. French Prospective Cohort" | Blood-Borne Infections, Digestive System Diseases, Flaviviridae infectious disease, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, arbovirus infection, cognitive disorder, hepatitis, hepatitis C virus infection, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, liver disorder, psychiatric disorder, sexually transmitted disease, uterine carcinosarcoma, vector-borne disease, viral hepatitis, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Not stated | 2026-02-17 | NCT07412977 | |
| ISTH/ANRS 0409s INTEGRATE Lassa Fever Study | Arenaviridae infectious disease, Communicable Diseases, Emerging, Disease Attributes, Infections, Lassa fever, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, infectious disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Phase 2 / Phase 3 | 2026-02-04 | NCT06212336 | |
| EBOla Post-Exposure Prophylaxis | Ebola hemorrhagic fever, Filoviridae infectious disease, Infections, Mononegavirales infectious disease, RNA Virus Infections, viral hemorrhagic fever, viral infectious disease | Not yet recruiting | Phase 3 | 2026-01-22 | NCT06841614 | |
| Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers | Ebola hemorrhagic fever, Filoviridae infectious disease, Infections, Mononegavirales infectious disease, RNA Virus Infections, viral hemorrhagic fever, viral infectious disease | Not yet recruiting | Phase 2 | 2026-01-22 | NCT05202288 | |
| Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 1 / Phase 2 | 2025-12-18 | NCT06821126 | |
| Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-positive bacterial infections, meningeal tuberculosis, meningitis, mycobacterial infectious disease, nervous system disorder, tuberculosis | Recruiting | Phase 2 | 2025-12-15 | NCT05590455 |